NASDAQ:CDMOP Avid Bioservices (CDMOP) Stock Price, News & Analysis → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free CDMOP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$25.06▼$25.0650-Day Range$25.03▼$25.3552-Week Range$21.00▼$31.95Volume400 shsAverage Volume11,021 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield10.49%Price TargetN/A Stock AnalysisStock Analysis Get Avid Bioservices alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About Avid Bioservices Stock (NASDAQ:CDMOP)Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.Read More Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. CDMOP Stock News HeadlinesApril 24, 2024 | sfgate.comAvid Bioservices: Fiscal Q3 Earnings SnapshotApril 24, 2024 | globenewswire.comAvid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024April 25, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.April 20, 2024 | seekingalpha.comLaughing Water Capital Q1 2024 LetterMarch 20, 2024 | finanznachrichten.deAvid Bioservices, Inc: Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-QMarch 20, 2024 | globenewswire.comAvid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-QMarch 16, 2024 | ca.finance.yahoo.comCDMO Jul 2024 2.500 callMarch 16, 2024 | ca.finance.yahoo.comCDMO Dec 2024 15.000 callApril 25, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.March 16, 2024 | finance.yahoo.comCDMO Apr 2024 7.500 callMarch 11, 2024 | finance.yahoo.comAvid Bioservices Inc (CDMO) Releases Preliminary Q3 Financial ResultsMarch 9, 2024 | morningstar.comAvid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsMarch 8, 2024 | seekingalpha.comAvid Bioservices Faces Financial Strain Amid Market Challenges (Rating Downgrade)March 6, 2024 | globenewswire.comAvid Bioservices Announces Pricing of Private Placement of Convertible NotesMarch 6, 2024 | globenewswire.comAvid Bioservices Announces Proposed Private Placement of Convertible NotesMarch 6, 2024 | globenewswire.comAvid Bioservices Announces Proposed Private Placement of Convertible NotesMarch 6, 2024 | globenewswire.comAvid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024March 6, 2024 | globenewswire.comAvid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024February 22, 2024 | benzinga.comAvid Bioservices Stock (NASDAQ:CDMO), Short Interest ReportFebruary 8, 2024 | seekingalpha.comLaughing Water Capital - Avid Bioservices: Substantial Future Earnings Power, Strong Competitive PositionJanuary 30, 2024 | insidermonkey.comAvid Bioservices (CDMO) Declined in 2023January 12, 2024 | finance.yahoo.comInsider Stock Buying Reaches US$527.5k On Avid BioservicesDecember 8, 2023 | investorplace.comWhy Is Avid Bioservices (CDMO) Stock Down 18% Today?December 8, 2023 | marketwatch.comAvid Bioservices Shares Drop 19% After 2Q Revenue Miss, Lowered FY GuidanceDecember 8, 2023 | msn.comPharma Contract Service Provider Avid Bioservices Reports Negative Gross Margin In Q3, Issues Meek OutlookDecember 8, 2023 | finance.yahoo.comAvid Bioservices, Inc. (NASDAQ:CDMO) Q2 2024 Earnings Call TranscriptDecember 5, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Alphatec Holdings (ATEC), Avid Bioservices (CDMO)See More Headlines Receive CDMOP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avid Bioservices and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:CDMOP CUSIPN/A CIK704562 Webwww.avidbio.com Phone714 508 6100FaxN/AEmployees222Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Daniel R. Hart (Age 48)Chief Financial Officer Comp: $488.87kMr. Mark R. Ziebell (Age 57)VP, Gen. Counsel & Corp. Sec. Comp: $662.28kMr. Nicholas Stewart Green (Age 56)Pres, CEO & Director Mr. Richard Richieri (Age 56)Chief Operations Officer Ms. Lorna LarsonSr. Director of HRMr. Timothy ComptonChief Commercial OfficerDr. Shelley P. M. Fussey (Age 55)VP of Intellectual Property Ms. Tracy L. KinjerskiVP of Bus. OperationsMr. Harold F. DvorakMedical & Scientific AdvisorProf. Alan J. SchroitMedical & Scientific AdvisorMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWAlpha Tau MedicalNASDAQ:DRTSWApollomicsNASDAQ:APLMWArtelo BiosciencesNASDAQ:ARTLWView All Competitors CDMOP Stock Analysis - Frequently Asked Questions Is Avid Bioservices a good dividend stock? Avid Bioservices (NASDAQ:CDMOP) pays an annual dividend of $2.63 per share and currently has a dividend yield of 9.49%. CDMOP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for CDMOP. This page (NASDAQ:CDMOP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avid Bioservices, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
